Correction: ERCC6L facilitates the progression of laryngeal squamous cell carcinoma by the binding of FOXM1 and KIF4A.
作者信息
Cui Meng, Chang Yu, Wang Jiheng, Wu Junfu, Li Gang, Tan Jie
机构信息
Department of Head and Neck Thyroid, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, 127 Dongming Road, Zhengzhou, 450008, People's Republic of China.
Department of Oncology, The First Affiliated Hospital of Zhengzhou University, 1 Jianshe Dong Road, Zhengzhou, 450007, People's Republic of China.
出版信息
Cell Death Discov. 2023 Aug 29;9(1):322. doi: 10.1038/s41420-023-01609-5.
Abstract
摘要
相似文献
1
Correction: ERCC6L facilitates the progression of laryngeal squamous cell carcinoma by the binding of FOXM1 and KIF4A.更正：ERCC6L 通过与 FOXM1 和 KIF4A 结合促进喉鳞状细胞癌的进展。
Cell Death Discov. 2023 Aug 29;9(1):322. doi: 10.1038/s41420-023-01609-5.
2
ERCC6L facilitates the progression of laryngeal squamous cell carcinoma by the binding of FOXM1 and KIF4A.ERCC6L通过与FOXM1和KIF4A结合促进喉鳞状细胞癌的进展。
Cell Death Discov. 2023 Feb 2;9(1):41. doi: 10.1038/s41420-023-01314-3.
3
FOXM1 promotes hepatocellular carcinoma progression by regulating KIF4A expression.FOXM1 通过调控 KIF4A 的表达促进肝癌进展。
J Exp Clin Cancer Res. 2019 May 9;38(1):188. doi: 10.1186/s13046-019-1202-3.
4
Hsa_circ_0042823 accelerates cancer progression miR-877-5p/FOXM1 axis in laryngeal squamous cell carcinoma.Hsa_circ_0042823 通过 miR-877-5p/FOXM1 轴促进喉鳞状细胞癌的进展。
Ann Med. 2021 Dec;53(1):960-970. doi: 10.1080/07853890.2021.1934725.
5
LncRNA MNX1-AS1 drives aggressive laryngeal squamous cell carcinoma progression and serves as a ceRNA to target FoxM1 by sponging microRNA-370.长链非编码RNA MNX1-AS1驱动喉鳞状细胞癌的侵袭性进展，并作为竞争性内源RNA通过海绵吸附微小RNA-370靶向FoxM1。
Aging (Albany NY). 2021 Mar 19;13(7):9900-9910. doi: 10.18632/aging.202746.
6
Overexpression of , , , and Coregulated Cell Cycle and Promoted Hepatocellular Carcinoma Development.过表达 、 、 、 和 共同调控细胞周期并促进肝细胞癌的发展。
J Comput Biol. 2020 Jun;27(6):965-974. doi: 10.1089/cmb.2019.0254. Epub 2019 Oct 9.
7
KIF4A enhanced cell proliferation and migration via Hippo signaling and predicted a poor prognosis in esophageal squamous cell carcinoma.KIF4A 通过 Hippo 信号通路增强食管鳞癌细胞的增殖和迁移，并预测其预后不良。
Thorac Cancer. 2021 Feb;12(4):512-524. doi: 10.1111/1759-7714.13787. Epub 2020 Dec 21.
8
ERCC6L is a biomarker and therapeutic target for non-small cell lung adenocarcinoma.ERCC6L是非小细胞肺腺癌的一种生物标志物和治疗靶点。
Med Oncol. 2022 Feb 12;39(5):51. doi: 10.1007/s12032-022-01654-7.
9
Deletion of Forkhead Box M1 transcription factor reduces malignancy in laryngeal squamous carcinoma cells.叉头框M1转录因子的缺失可降低喉鳞状癌细胞的恶性程度。
Asian Pac J Cancer Prev. 2011;12(7):1785-8.
10
ERCC6L promotes the progression of hepatocellular carcinoma through activating PI3K/AKT and NF-κB signaling pathway.ERCC6L 通过激活 PI3K/AKT 和 NF-κB 信号通路促进肝癌的进展。
BMC Cancer. 2020 Sep 5;20(1):853. doi: 10.1186/s12885-020-07367-2.
Zotero 插件